Drug companies reach $260M settlement just ahead of opioid trial; Oyster Point set terms for $85M IPO
→ Hours before the first federal opioid trial was set to begin, three drug distributors and an opioid manufacturer agreed to a $260 million agreement …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
